Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections


To examine the effect of Point-of-Care Ultrasound (POCUS) management guidance on pediatric skin and soft tissue infections treatment failure rate, as well as emergency department process outcome.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 2015

Arms, Groups and Cohorts

  • Ultrasound
    • those who received point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections
  • No Ultrasound
    • those who did not receive point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections

Clinical Trial Outcome Measures

Primary Measures

  • treatment failure rate
    • Time Frame: 7-10days
    • unscheduled return visits need for subsequent procedural intervention need for subsequent admission change in therapy

Secondary Measures

  • emergency department process outcome
    • Time Frame: 7-10days
    • emergency department (ED) length of stay, need for ED procedural sedation use of alternative imaging in ED

Participating in This Clinical Trial

Inclusion Criteria

  • history and examination findings consistent with possible abscess or cellulitis per the treating clinician.
  • minimal lesion diameter for inclusion is 1cm.

Exclusion Criteria

  • suspected soft tissue infections involving or near mucosal membranes (e.g. perirectal, peritonsillar, vulvovaginal areas)
  • facial lesions
  • paronychia or felon
  • parent or patient refusal of consent
  • unsuitable subjects deemed by treating clinicians.

Gender Eligibility: All

Minimum Age: 6 Months

Maximum Age: 19 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • May Alrahi
  • Collaborator
    • American College of Emergency Physicians
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: May Alrahi, Principal Investigator – Advocate Health Care
  • Overall Official(s)
    • Samuel Lam, MD, Principal Investigator, Advocate Christ Medical Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.